相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surgery and prophylactic surgery in hereditary breast cancer
Monica Morrow
BREAST (2022)
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
H. S. Rugo et al.
ANNALS OF ONCOLOGY (2022)
Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective
Marc D. Piroth et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2022)
Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies
Sebastian Rubino et al.
FRONTIERS IN ONCOLOGY (2022)
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2021)
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N. Harbeck et al.
ANNALS OF ONCOLOGY (2021)
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer
Giulia Petroni et al.
CLINICAL CANCER RESEARCH (2021)
Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer
Kristine N. Kim et al.
BREAST (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+breast cancer brain metastases
Matthew N. Mills et al.
BMC CANCER (2021)
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review
Gianluca Ingrosso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis
M. G. Davey et al.
BREAST (2021)
Moving Forward Fast with FAST-Forward
P. Lewis et al.
CLINICAL ONCOLOGY (2021)
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)
Laura Biganzoli et al.
LANCET ONCOLOGY (2021)
Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology)
Isabella Palumbo et al.
JOURNAL OF GERIATRIC ONCOLOGY (2021)
Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
Diego Cortinovis et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases
Shireen Parsai et al.
JOURNAL OF NEUROSURGERY (2020)
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper
Vincenzo Valentini et al.
RADIOTHERAPY AND ONCOLOGY (2020)
A phase 2 clinical trialassessing theefficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer
Alice Y. Ho et al.
CANCER (2020)
Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer
Shir Schlosser et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review
Lei Liu et al.
RADIATION ONCOLOGY (2020)
Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature
Igor Makhlin et al.
CURRENT ONCOLOGY REPORTS (2020)
Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm
I. Meattini et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer
Ivica Ratosa et al.
CLINICAL BREAST CANCER (2020)
Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
Michelle Tseng et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
Nadine M. Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt et al.
LANCET (2020)
Bone health in cancer: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2020)
The 2018 assisi think tank meeting on breast cancer: International expert panel white paper
Meritxell Arenas et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
Neda Stjepanovic et al.
EUROPEAN JOURNAL OF CANCER (2020)
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
Adrian Murray Brunt et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2020)
Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases
Morgan Guenole et al.
BMC CANCER (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
Yilan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
Fabio Marazzi et al.
CANCERS (2020)
Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity
Paul T. Winnard et al.
PLOS ONE (2020)
Apples and oranges: comparing partial breast irradiation techniques
Orit Kaidar-Person et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2020)
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine
Pierfrancesco Franco et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients
Alexandra J. van den Brock et al.
ANNALS OF SURGERY (2019)
Omitting Adjuvant Radiotherapy for Hormone Receptor-Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis
Yi-Jun Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
Shu-Lian Wang et al.
LANCET ONCOLOGY (2019)
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis
Joseph M. Kim et al.
NEURO-ONCOLOGY (2019)
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade
Michael T. Milano et al.
RADIOTHERAPY AND ONCOLOGY (2019)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Kelly Metcalfe et al.
BRITISH JOURNAL OF CANCER (2019)
Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view
Alexis Vallard et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease
Robbe Van den Begin et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Quantifying the relationship between age at diagnosis and breast cancer-specific mortality
Helen M. Johnson et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Bernadette A. M. Heemskerk-Gerritsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists
Elysia Donovan et al.
BREAST JOURNAL (2019)
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
P. H. Patel et al.
CLINICAL ONCOLOGY (2019)
BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
Mai Elezaby et al.
RADIOLOGY (2019)
Is bilateral radiation an option for BRCA mutation carriers with unilateral breast cancer?
Steven A. Narod
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases
Nicholas B. Figura et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Contralateral breast irradiation in BRCA carriers: the conundrum of prophylactic versus early treatment
P. M. P. Poortmans et al.
ANNALS OF ONCOLOGY (2019)
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
E. Evron et al.
ANNALS OF ONCOLOGY (2019)
Surgical treatment and prognosis of breast cancer in elderly - A population-based study
Kaisu Ojala et al.
EJSO (2019)
Comprehensive Geriatric Assessment as a Versatile Tool to Enhance the Care of the Older Person Diagnosed with Cancer
Janine Overcash et al.
GERIATRICS (2019)
Stereotactic radiotherapy in metastatic breast cancer
Marco Possanzini et al.
BREAST (2018)
Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival
S. E. Ward et al.
BRITISH JOURNAL OF SURGERY (2018)
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group
Nandita M. deSouza et al.
EUROPEAN JOURNAL OF CANCER (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial
Rebekka Schaefer et al.
LANCET ONCOLOGY (2018)
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
Ellen R. Copson et al.
LANCET ONCOLOGY (2018)
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis
Julian C. Hong et al.
PLOS ONE (2018)
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
Joanne S. Haviland et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Oncology: Management of Elderly Cancer Patients
Meritxell Arenas et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial
Puneeth Iyengar et al.
JAMA ONCOLOGY (2018)
Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy
Taylor R. Cushman et al.
IMMUNOTHERAPY (2018)
What is Comprehensive Geriatric Assessment (CGA)? An umbrella review
S. G. Parker et al.
AGE AND AGEING (2018)
Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer
Claudia Martinez-Tapia et al.
EUROPEAN JOURNAL OF CANCER (2017)
A multinational report of technical factors on stereotactic body radiotherapy for oligometastases
Kristin J. Redmond et al.
FUTURE ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
Charlotte E. Coles et al.
LANCET (2017)
Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer
Elena Muraro et al.
FRONTIERS IN IMMUNOLOGY (2017)
Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer The POSH Observational Cohort Study
Tom Maishman et al.
ANNALS OF SURGERY (2017)
A multi-national report on stereotactic body radiotherapy for oligometastases: Patient selection and follow-up*
Roi Dagan et al.
ACTA ONCOLOGICA (2016)
The 2016 Assisi Think Tank Meeting on breast cancer: white paper
Cynthia Aristei et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
Anthony C. Wong et al.
CANCER (2016)
Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management
Rohann J. M. Correa et al.
CANCER JOURNAL (2016)
High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study
Baptiste Pichon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers
Alexandra J. van den Broek et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
Abram Recht et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
Vratislav Strnad et al.
LANCET (2016)
Clinical development of new drug-radiotherapy combinations
Ricky A. Sharma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: A review
Jacques Bernier et al.
BREAST (2015)
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
Lorenzo Livi et al.
EUROPEAN JOURNAL OF CANCER (2015)
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Ian H. Kunkler et al.
LANCET ONCOLOGY (2015)
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis
Antonis Valachis et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
Pierre Soubeyran et al.
PLOS ONE (2014)
Systemic Treatment Considerations for Women with BRCA1/2-Associated Breast Cancer
Ella Evron et al.
CURRENT BREAST CANCER REPORTS (2014)
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2013)
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
Jonine L. Bernstein et al.
EUROPEAN JOURNAL OF CANCER (2013)
Omission of surgery in elderly patients with early stage breast cancer
Marije E. Hamaker et al.
EUROPEAN JOURNAL OF CANCER (2013)
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer
Tomasz Huzarski et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
Kimberly S. Corbin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial
Csaba Polgar et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli et al.
LANCET ONCOLOGY (2012)
Impact of Evidence-Based Clinical Guidelines on the Adoption of Postmastectomy Radiation in Older Women
Shervin M. Shirvani et al.
CANCER (2011)
MicroRNA Expression Characterizes Oligometastasis(es)
Yves A. Lussier et al.
PLOS ONE (2011)
Radiotherapy in the Treatment of Hereditary Breast Cancer
Lori J. Pierce et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
The impact of the loco-regional treatment in elderly breast cancer patients: Hypo-fractionated exclusive radiotherapy, single institution long-term results
Cyrus Chargari et al.
BREAST (2010)
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature
Youlia M. Kirova et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
Lori J. Pierce et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Use of postmastectomy radiotherapy in older women
Benjamin D. Smith et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Stereotactic body radiotherapy for oligometastatic lung tumors
Yoshiki Norihisa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
DOSE TO THE CONTRALATERAL BREAST FROM RADIOTHERAPY AND RISK OF SECOND PRIMARY BREAST CANCER IN THE WECARE STUDY
Marilyn Stovall et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
DESCRIPTIVE ANALYSIS OF OLIGOMETASTATIC LESIONS TREATED WITH CURATIVE-INTENT STEREOTACTIC BODY RADIOTHERAPY
Michael T. Milano et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast Cancer
Maartje J. Hooning et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
Hans Wildiers et al.
LANCET ONCOLOGY (2007)
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom
Susan Shanley et al.
CLINICAL CANCER RESEARCH (2006)
Postmastectomy radiation and survival in older women with breast cancer
Benjamin D. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients
Adel Courdi et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-con serving surgery and radiotherapy
YM Kirova et al.
EUROPEAN JOURNAL OF CANCER (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
LC Hartmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Frailty in older adults: Evidence for a phenotype
LP Fried et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)
Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
